End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 EUR | -9.59% | -5.71% | -10.20% |
2021 | Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021 | CI |
2021 | Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company appears to be poorly valued given its net asset value.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- One of the major weak points of the company is its financial situation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.20% | 12.23M | - | ||
-3.32% | 184B | C+ | ||
-2.21% | 107B | C | ||
-4.18% | 67.78B | A | ||
+0.86% | 50.66B | B- | ||
+10.59% | 47.64B | B- | ||
+4.60% | 41.12B | B+ | ||
+1.07% | 26.3B | B | ||
+1.22% | 26.04B | A- | ||
+15.06% | 25.4B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AAQ1 Stock
- AAQ Stock
- Ratings aap Implantate AG